A Hard Look at Cardiac Safety with Dopamine Agonists in Endocrinology Comment

被引：4
作者：
Daly, Adrian F. [1 ]
Beckers, Albert [1 ]
机构：
[1] Univ Liege, Ctr Hosp Univ Liege, Dept Endocrinol, Domaine Univ Sart Tilman, B-4000 Liege, Belgium
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2021年 / 106卷 / 06期
关键词：
hyperprolactinemia; dopamine agonist; valvulopathy; safety; echocardiography; cabergoline; bromocriptine; CABERGOLINE; DISEASE;
D O I：
10.1210/clinem/dgab073
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E2452 / E2454
页数：3
相关论文
共 10 条
[1]   Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma [J].
Coopmans, Eva C. ;
van Meyel, Sebastiaan W. F. ;
Pieterman, Kay J. ;
van Ipenburg, Jolique A. ;
Hofland, Leo J. ;
Donga, Esther ;
Daly, Adrian F. ;
Beckers, Albert ;
van der Lely, Aart-Jan ;
Neggers, Sebastian J. C. M. M. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (02) :K21-K27
[2]   The Epidemiology of Pituitary Adenomas [J].
Daly, Adrian F. ;
Beckers, Albert .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2020, 49 (03) :347-+
[3]   The Role of Surgery in the Management of Prolactinomas [J].
Donoho, Daniel A. ;
Laws, Edward R., Jr. .
NEUROSURGERY CLINICS OF NORTH AMERICA, 2019, 30 (04) :509-+
[4]   Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do [J].
Sherlock, Mark ;
Toogood, Andy A. ;
Steeds, Richard .
HEART, 2009, 95 (07) :522-523
[5]   Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology [J].
Steeds, Richard ;
Stiles, Craig ;
Sharma, Vishal ;
Chambers, John ;
Lloyd, Guy ;
Drake, William .
CLINICAL ENDOCRINOLOGY, 2019, 90 (05) :662-669
[6]   A Meta-Analysis of the Prevalence of Cardiac Valvulopathy in Patients With Hyperprolactinemia Treated With Cabergoline [J].
Stiles, Craig E. ;
Tetteh-Wayoe, Eugene T. ;
Bestwick, Jonathan P. ;
Steeds, Richard P. ;
Drake, William M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (02) :523-538
[7]   Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints [J].
Stiles, Craig Edward ;
Lloyd, Guy ;
Bhattacharyya, Sanjeev ;
Steeds, Richard Paul ;
Boomla, Kambiz ;
Bestwick, Jonathan Paul ;
Drake, William Martyn .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (02) :E711-E720
[8]   Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease [J].
Van Camp, G ;
Flamez, A ;
Cosyns, B ;
Weytjens, C ;
Muyldermans, L ;
Van Zandijcke, M ;
De Sutter, J ;
Santens, P ;
Decoodt, P ;
Moerman, C ;
Schoors, D .
LANCET, 2004, 363 (9416) :1179-1183
[9]   Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients [J].
Vroonen, Laurent ;
Jaffrain-Rea, Marie-Lise ;
Petrossians, Patrick ;
Tamagno, Gianluca ;
Chanson, Philippe ;
Vilar, Lucio ;
Borson-Chazot, Francoise ;
Naves, Luciana A. ;
Brue, Thierry ;
Gatta, Blandine ;
Delemer, Brigitte ;
Ciccarelli, Enrica ;
Beck-Peccoz, Paolo ;
Caron, Philippe ;
Daly, Adrian F. ;
Beckers, Albert .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (05) :651-662
[10]   Valvular heart disease and the use of dopamine agonists for Parkinson's disease [J].
Zanettini, Renzo ;
Antonini, Angelo ;
Gatto, Gemma ;
Gentile, Rosa ;
Tesei, Silvana ;
Pezzoli, Gianni .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :39-46
1